Cellectis SA (NASDAQ:CLLS)
| 10.85 Delayed Data As of Oct 15 |  +0.15 / +1.40%Today’s Change | 8.72 Today|||52-Week Range 34.71 | -59.90% Year-to-Date |
Latest CLLS News | Press Releases
No recent news for Cellectis SA.
Today’s Trading
| Previous close | 10.70 |
| Today’s open | 10.59 |
| Day’s range | 10.47 - 10.86 |
| Volume | 24,350 |
| Average volume (3 months) | 208,255 |
| Market cap | $415.1M |
Data as of 3:59pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | +20.70% |
| Earnings growth (this year) | -38.64% |
| Earnings growth (next 5 years) | +1.50% |
| Revenue growth (last year) | +386.83% |
| P/E ratio | NM |
| Price/Sales | 15.55 |
| Price/Book | 1.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --China Health Group I... | -0.01 | -1.01% |
| OMEROmeros Corp | +0.01 | +0.13% |
| VKTXViking Therapeutics ... | -0.15 | -2.44% |
| ---- |
Data as of 4:13pm ET, 10/15/2021
Financials
| Next reporting date | November 16, 2021 |
| EPS forecast (this quarter) | -$0.82 |
| Annual revenue (last year) | $73.9M |
| Annual profit (last year) | -$81.1M |
| Net profit margin | -109.64% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
